We have been collaborating for over a decade with leading educational and healthcare institutions.
To this day, our devices are featured in the most published research in the field of photobiomodulation.
Photobiomodulation research
Research With
Huelight Technology
500+
clinical research participants
500+
clinical research participants
500+
clinical research participants
- All
- WB-PBM Therapy
- Hyperbaric Oxygen Therapy
- Hydrogen Therapy
- Sonicwave
- All
- Alzheimer's disease
- Brain injury
- Hemorrhage
- Lymphatic drainage
- Parkinson's Disease
- Stroke
A Brief Review of Low-Level Light Therapy for Mood Disorders
WB-PBM Therapy
PBM therapy increases ATP production, improves blood circulation, reduces inflammation, promotes healing, and stimulates stem cell growth. Preclinical studies indicate that PBM may enhance cognitive function in Alzheimer’s patients, relieve motor symptoms in Parkinson’s disease, and reduce depressive symptoms.
2023, Faculty of Medicine, University of Sydney, NSW, Australia ________________________________________
Remote PBM Targeting the Abdomen or Legs Provides Neuroprotection in Parkinson’s MPTP Models
WB-PBM Therapy
PBM protected key neural pathways affected by MPTP-induced Parkinson’s disease (PD). The abdomen and legs were both effective as remote PBM therapy targets.
2023, Faculty of Medicine, University of Sydney, NSW, Australia
Restoring Cognitive Function in Chronically Stressed Rats via Brain-Gut PBM Therapy: The Role of Sirt1 and Neuroinflammation
WB-PBM Therapy
Chronic Unpredictable Mild Stress (CUMS) protocols significantly induced behavioral deficits and increased hippocampal Sirt1 levels. PBM therapy reversed cognitive impairment caused by CUMS. PBM normalized hippocampal Sirt1 levels, prevented spine density loss in the CA1 region, altered gut microbiota composition, reduced neuroinflammation, and regulated microglial morphology.
2024, University of Barcelona, Faculty of Medicine, Department of Biomedicine, Neuroscience Institute, Spain ________________________________________
PBM enhances neuronal metabolism, supports neurogenesis, and reduces inflammation. Success in depression treatment has sparked interest in PBM’s potential for Parkinson’s disease and dementia.
2024, School of Materials Science and Engineering, Hefei University of Technology, Hefei, China
Parkinson’s Disease and PBM: A Therapeutic Possibility
WB-PBM Therapy
PBM improves mitochondrial function, increases ATP production, and reduces inflammation. Clinically, PBM aids in wound healing, pain management, and swelling reduction. It has shown potential neuroprotective effects and symptom relief in Parkinson’s disease.
2024, NICM Health Research Institute, Western Sydney University, Westmead, Australia
PBM for Neuropathic Pain Management (808 nm)
WB-PBM Therapy
Data suggests that 808 nm PBM reduces neuropathic pain. Higher energy densities (20 and 40 J/cm²) were more effective and stimulated greater β-endorphin production.
2017, Federal University of São Carlos (UFSCar), Department of Physical Therapy, São Carlos, Brazil
PBM Therapy for Post-Operative Cognitive Dysfunction (POCD): Evidence from Cytoskeletal Assembly/Disassembly
WB-PBM Therapy
PBM effectively reduced neuroinflammation and provided pain relief by influencing cytoskeletal dynamics.
2015, University of Sydney, Faculty of Medicine, Sydney, Australia
Stopping Neurodegeneration with Light: The Potential of Near-Infrared Therapy for Alzheimer’s and Parkinson’s Disease
WB-PBM Therapy
Though still in early research stages, near-infrared (NIr) therapy shows promise as a safe and effective neuroprotective treatment for Alzheimer’s and Parkinson’s patients.
2015, Department of Physiology, University of Sydney, NSW, Australia
PBM was found to be a safe and potentially effective treatment for various clinical signs and symptoms of Parkinson’s disease.
2021, Faculty of Medicine, University of Sydney, Camperdown, Australia
주요 우울 장애를 위한 경두개 광생물조절의 리뷰: 뇌 대사, 염증, 산화 스트레스 및 신경생성을 목표로 함
WB-PBM Therapy
이 논문에서 검토한 예비 데이터는 우울증, 불안, 인지 장애 치료에 대한 경두개 PBM의 효과를 제안한다.
2016년, 미국 매사추세츠 주 보스턴 02114, 보우도인 스퀘어 1번지 6층, 매사추세츠 종합병원 우울증 임상 및 연구 프로그램
PBM for Neuropathic Pain Management (808 nm)
WB-PBM Therapy
Data suggests that 808 nm PBM reduces neuropathic pain. Higher energy densities (20 and 40 J/cm²) were more effective and stimulated greater β-endorphin production.
2017, Federal University of São Carlos (UFSCar), Department of Physical Therapy, São Carlos, Brazil
Remote PBM Targeting the Abdomen or Legs Provides Neuroprotection in Parkinson’s MPTP Models
WB-PBM Therapy
PBM protected key neural pathways affected by MPTP-induced Parkinson’s disease (PD). The abdomen and legs were both effective as remote PBM therapy targets.
2023, Faculty of Medicine, University of Sydney, NSW, Australia
